InMode OptimasMAX
IPL/RF platform · Multi-application IPL and RF platform
Technology: IPL
Classification & configurations
Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)
At a glance
- New price
- Not published
- FDA status
Record scope: 510(k): K251632 (decision 26 Jun 2025). Checked 4 Sep 2026.
- Supplies & recurring costs
- Supply details not yet documented.
Sources and data on file
Data on file
- Recurring consumables
- Not verified
- FDA
- FDA record cited — see scopeK251632
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers.
Read FDA-cleared indicationsExact wording from 1 FDA record
K251632 (InMode, Ltd., 2025)
The Optimas MAX System with the Diolaze XL MAX is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. The Fusion Light and the Fusion Dark are intended for hair removal. The Optimas MAX System with the VasculazeMAX is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The Optimas MAX System with the Lumecca Peak Applicators are indicated for use for the following treatments: * The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); * The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, superficial leg veins and venous malformations. The Optimas MAX System with the Plus and Forma Handpieces are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation The Optimas MAX System with the he Morpheus8 Applicators is intended for use in dermatologic procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 Applicator is limited to Skin Types I-IV.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: October 6, 2026 · How we verify
New-equipment price not yet documented
For a complete budget, ask for an itemized quote covering the device, accessories, training and service.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | InMode |
|---|---|
| Company | Owner: Publicly traded (NASDAQ: INMD; no single controlling owner) (public company, since 2019) · Distribution: direct |
| Parent company | InMode |
| Brand owner | InMode |
| Built by (OEM) | InMode Ltd. |
| Category | IPL/RF platform |
| Technology | Multi-application IPL and RF platform |
| FDA status | FDA record cited — see scope |
| 510(k) citation | K251632 |
| New price range | Not published |
| Used price reference | Not published |
| Consumables | Not published |
| Launch year | Not published |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
OptimasMAX is an InMode workstation combining multiple treatment technologies, including fractional RF, IPL and laser handpieces. Modules are selected for the practice’s intended services; confirm the exact handpieces and their indications in the equipment quote.
FDA & regulatory detailClearance timeline, authorization route and citation notes
510(k): K251632 (decision 26 Jun 2025). Checked 4 Sep 2026.
FDA-cleared indications (verbatim)
K251632 (InMode, Ltd., 2025)
The Optimas MAX System with the Diolaze XL MAX is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. The Fusion Light and the Fusion Dark are intended for hair removal. The Optimas MAX System with the VasculazeMAX is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The Optimas MAX System with the Lumecca Peak Applicators are indicated for use for the following treatments: * The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); * The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, superficial leg veins and venous malformations. The Optimas MAX System with the Plus and Forma Handpieces are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation The Optimas MAX System with the he Morpheus8 Applicators is intended for use in dermatologic procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 Applicator is limited to Skin Types I-IV.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
IPL — Multi-application IPL and RF platform
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: InMode
Legal manufacturer: InMode Ltd. (Israel)
Applicant on the FDA record
InMode Ltd.The applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatment and running-cost details aren’t documented yet.
Ask the supplier for the session schedule, supplies per treatment and annual service costs.
Use your own figures in the calculatorPayback calculatorEnter your quote, volume and running costs
Estimate your payback
Enter your quote and treatment costs for InMode OptimasMAX. Published figures appear where available; review them before using the estimate.
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
New price not published — enter the number on your quote.
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Required — include staff time and your own time. Enter 0 only to explicitly exclude labor from this estimate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter purchase price, price you charge per treatment, consumable cost per treatment, labor cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
No current alternatives identified in the catalog yet. Browse current models
History15 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
October 6, 2026
InMode model description and documentation
{"product_url": null} → {"product_url": "https://www.inmodemd.com/workstation/optimas-max/"}
Primary-source review on October 6, 2026 of the changed fields only. Prices, lifecycle status, regulatory fields and current US service arrangements are not verified by this update.
Source: https://www.inmodemd.com/workstation/optimas-max/
October 1, 2026
Price model and package scope
The recorded new range combines a dealer ask without confirmed new-unit condition and loaded-package forum quotes. The MAX model, condition and package are not established consistently across both endpoints.
Source: Catalog update
October 1, 2026
Used price range
39950-74950 → —
Source: Catalog update
October 1, 2026
New price range
125899-275000 → —
Source: Catalog update
October 1, 2026
Price model and package scope
The recorded asking range describes Optimas platforms from multiple years without establishing MAX-model identity. A MAX-specific range is not documented.
Source: Catalog update
October 1, 2026
Price model and package scope
{"used_price_range": "39950-74950"} → {"used_price_range": null}
The recorded asking range describes Optimas platforms from multiple years without establishing MAX-model identity. A MAX-specific range is not documented.
Source: Catalog update
October 1, 2026
Price model and package scope
{"new_price_range": "125899-275000"} → {"new_price_range": null}
The recorded new range combines a dealer ask without confirmed new-unit condition and loaded-package forum quotes. The MAX model, condition and package are not established consistently across both endpoints.
Source: Catalog update
October 1, 2026
Sourced profile overview
Added a neutral overview from the linked manufacturer or official US distributor source. This is field-specific sourcing, not verification of every other profile field.
Source: https://www.inmodemd.com/workstation/optimas-max/
September 4, 2026
510(k) numbers
K-number set re-verified against openFDA
Source: Council round 2 audit, verified on openFDA 2026-09-04
September 4, 2026
FDA source URL
Source: Catalog update
September 4, 2026
FDA K-numbers
Source: Catalog update
September 4, 2026
FDA status
Unknown → Cleared
Source: Catalog update
September 4, 2026
FDA status
Unknown → Cleared
Clearance located on openFDA
Source: Council round 2 audit, verified on openFDA 2026-09-04
August 30, 2026
New price range
125899-275000
Source: Catalog update
August 30, 2026
Used price range
39950-74950
Source: Catalog update
Cite this data: The Aesthetic Index, "InMode OptimasMAX — pricing, FDA status and cost to own", aestheticindex.co (accessed November 3, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.